Subscribe


Pharmacy DailyAbout Pharmacy Daily

Pharmacy Daily is Australia’s favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country. Pharmacy Daily is aimed at people working in the pharmacy industry – pharmacists, dispensary assistants and shop staff as well as people working in manufacturing and hospital pharmacy. Currently more than 12,500 people read Pharmacy Daily, with numbers growing every day.

Pharmacy Daily is renowned for breaking the big pharmacy industry stories and has close links with the Pharmacy Guild, Pharmaceutical Society of Australia and other government and industry bodies as well as wholesalers and other suppliers, making the free publication the best way to keep fully informed about the industry.

Editorial Opportunities

Pharmacy Daily aims to bring the most up-to-date and relevant information to the industry each day. Accordingly we welcome any relevant newsworthy editorial – new products, news releases, appointments and any special offers. We also publish photographs of industry events and anything else of interest so keep those cameras handy!

If you need to reach the Australian pharmacy industry with timely, up-to-date information Pharmacy Daily is an ideal medium. All editorial contributions can be emailed to info@pharmacydaily.com.au or faxed to 1300 799 221 or +61 2 8007 6769.

Advertising

Pharmacy Daily is a highly cost-effective advertising medium for the pharmacy industry. Rates are extremely reasonable and because the newsletter is well-read it provides a targeted way to get your product out there.

Click here for more information about advertising in Pharmacy Daily.

How do I get Pharmacy Daily

Eligible industry staff can click here to register their details to receive Pharmacy Daily at no charge.

More Information

Anyone wanting more information on Pharmacy Daily can contact us on info@pharmacydaily.com.au, by phone on 1300 799 220 (within Australia) or +61 2 8007 6760 (overseas). Our fax number is 1300 799 221 (within Australia) or +61 2 8007 6769.



Latest Pharmacy Daily headlines

Fri 20 Oct 17

Intrepid Instigos raise $8K


FOUR Instigo staff took the leap to abseil down 33 floors down a Sydney CBD building, (on the somewhat inauspicious date of last Fri 13 Oct) to support young Australians facing addiction, mental health illness, homelessness and unemployment.


Fri 20 Oct 17

Guild-PSA codeine resources


ANTICIPATING the needs of community pharmacies around Australia, the Pharmacy Guild of Australia and the Pharmaceutical Society of Australia (PSA) have collaborated under Federal Government funding to develop resources in preparation for the 01 Feb 2018 transition of medicines containing codeine becoming Prescription Only.


Fri 20 Oct 17

Vic confirms recording roll-out


Pharmacy Daily

VICTORIA is pressing ahead with its own $29.5 million real-time prescription monitoring system, with enabling legislation passing the state's parliament yesterday.


Thu 19 Oct 17

Codeine letter revealed


Pharmacy Daily

A joint letter to Australia's health ministers penned by doctors' groups, Pain Australia and the Consumers Health Forum has been made public, with the organisations reiterating the Therapeutic Goods Administration's key findings from the review of codeine use.


Thu 19 Oct 17

Ailments scheme urged


Pharmacy Daily

IMPLEMENTING self-care policies such as pharmacy-based minor ailments services is a cost-effective way to reduce the load on hospital emergency departments, according to a presentation yesterday at the World Self Medication Industry General Assembly in Sydney.


Thu 19 Oct 17

PD breaking news – API announces growth in tougher retail environment


Pharmacy Daily

API announces growth in tougher retail environmentAustralian Pharmaceutical Industries (API)  has announced its FY results with underlying net profit after tax (NPAT) of $54.2m for the year ending 31 Aug 2017, up 5.4% on the previous year and slightly ahead of the company's profit guidance issued 02 Aug.Total revenue for the period increased 5.8% to $4.04b with reported EBITDA up 3.8% to $117.9m and underlying EBITDA up 6.1% to $120.5m.There was no reported net debt at the end of the financial year, which was achieved earlier than the company's guidance that it would reach this objective by calendar year end.


View All news articles Subscribe to the Newsletter